aslan
pharmaceuticals
present
wainwright
annual
global
investment
conference
singapore
globe
newswire
aslan
pharmaceuticals
nasdaq
asln
immunology
oncology
focused
biopharmaceutical
company
developing
innovative
treatments
transform
lives
patients
today
announced
presentation
wainwright
annual
global
investment
conference
dr
carl
firth
chief
executive
officer
scheduled
make
company
presentation
september
edt
virtual
conference
held
september
presentation
deck
used
conference
available
investors
section
aslan
website
following
event
media
ir
contacts
emma
thompson
spurwing
communications
tel
email
aslan
robert
uhl
westwicke
partners
tel
email
aslan
pharmaceuticals
aslan
pharmaceuticals
nasdaq
asln
immunology
oncology
focused
biopharmaceutical
company
developing
innovative
treatments
transform
lives
patients
led
senior
management
team
extensive
experience
global
development
commercialisation
aslan
clinical
portfolio
comprised
first
class
monoclonal
therapy
developed
atopic
dermatitis
immunology
indications
small
molecule
inhibitor
targeting
oncology
aslan
partners
include
almirall
array
biopharma
squibb
csl
additional
information
please
visit
forward
looking
statements
release
accompanying
financial
information
contains
statements
statements
based
current
beliefs
expectations
management
aslan
pharmaceuticals
limited
affiliates
company
statements
may
include
limited
statements
regarding
company
business
strategy
company
plans
develop
commercialise
product
candidates
safety
efficacy
company
product
candidates
company
plans
expected
timing
respect
regulatory
filings
approvals
size
growth
potential
markets
company
product
candidates
company
estimates
projections
statements
based
management
current
assumptions
expectations
future
events
trends
affect
may
affect
company
business
strategy
operations
financial
performance
inherently
involve
significant
known
unknown
risks
uncertainties
actual
results
timing
events
could
differ
materially
anticipated
statements
result
risks
uncertainties
include
without
limitation
risk
factors
described
company
securities
exchange
commission
filings
reports
commission
file
including
company
form
filed
securities
exchange
commission
sec
april
statements
statements
historical
fact
statements
words
believe
may
might
could
aim
estimate
continue
anticipate
intend
expect
plan
negative
terms
similar
expressions
convey
uncertainty
future
events
outcomes
intended
identify
estimates
projections
statements
estimates
projections
statements
speak
date
made
except
extent
required
law
company
undertakes
obligation
update
review
estimate
projection
statement
